Table 2.
Summary of Published Recommendations and Hospital Guidelines for Screening of Carpal Tunnel Syndrome in the Mucopolysaccharidoses.
| Study (country) | MPS type | Starting age of screening | Screening intervals | ||
|---|---|---|---|---|---|
| Clinical examination | NCS | Clinical examination | NCS | ||
| Viskochil et al 201710 (USA) | IH | – | 3 y | ||
| IHS/S | – | 5-7 y | |||
| Argenta et al 201711 (USA) | II | 3 y | 3 y | ||
| Jadhav et al 20155 (Australia) | I, II, IV | 4 y | |||
| White et al 20107 (USA) | unspecified | At diagnosis | At diagnosis | 1 y | 1-3 y |
| Muenzer et al 200924 (USA) | II | At diagnosis | 4-5 y | 1 y | 1-2 y |
| Khanna et al 200720 (USA) | IH | 1 y after HSCT | 1 y | ||
| Vellodi et al 201114 (England) | I, II, VI | 3-mo | 1 y | ||
| Crushell 2019 (Ireland)a | IH | At diagnosis | 4-5 y | 1.5-2 y (if initial NCS normal) ½-1 y (if initial NCS mildly abnormal) |
|
| Lampe 2019 (Germany)a | I, II, VI, VII | At diagnosis | At diagnosis | 1-2 y | 1-2 y |
| Lagler 2019a (Austria)a | unspecified | At diagnosis | At diagnosis | ½ y | 1 y |
Abbreviations: CTS, carpal tunnel syndrome; HSCT, hematopoietic stem cell transplantation; MPS, mucopolysaccharidosis; NCS, nerve conduction studies.
aPersonal email correspondence.